Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Neuroscientific Biopharmaceuticals Ltd. ( (AU:NSB) ) just unveiled an update.
Neuroscientific Biopharmaceuticals Ltd. has announced an expansion in manufacturing capacity through a technology transfer with Q-Gen, enhancing its supply chain for stem cell solutions. The company has demonstrated proven clinical efficacy with a 78% overall response rate in a refractory Crohn’s trial, positioning itself strongly in the market for auto-immune disorder treatments.
More about Neuroscientific Biopharmaceuticals Ltd.
Neuroscientific Biopharmaceuticals Ltd. operates in the biopharmaceutical industry, focusing on developing patented stem cell solutions for complex auto-immune disorders and unmet medical needs. The company boasts a robust market cap of approximately $50 million and holds $7.3 million in cash, supported by a strong leadership team with extensive experience in biotechnology and financial services.
Average Trading Volume: 502,544
Technical Sentiment Signal: Buy
Current Market Cap: A$49.89M
For an in-depth examination of NSB stock, go to TipRanks’ Overview page.